Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus

被引：0
作者：
Kim, Gwang Ha [1 ,2 ]
机构：
[1] Pusan Natl Univ, Sch Med, Dept Internal Med, Busan 602739, South Korea
[2] Pusan Natl Univ Hosp, Biomed Res Inst, Busan, South Korea
来源：
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY | 2015年 / 21卷 / 02期
关键词：
PROTON PUMP INHIBITORS; GASTRIN; CANCER;
D O I：
10.5056/jnm15004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：288 / 289
页数：2
相关论文
共 11 条
  • [1] Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenes
    Abdalla, SI
    Lao-Sirieix, P
    Novelli, MR
    Lovat, LB
    Sanderson, IR
    Fitzgerald, RC
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (14) : 4784 - 4792
  • [2] Case-control analysis on metformin and cancer of the esophagus
    Becker, Claudia
    Meier, Christoph R.
    Jick, Susan S.
    Bodmer, Michael
    [J]. CANCER CAUSES & CONTROL, 2013, 24 (10) : 1763 - 1770
  • [3] Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence
    Cooper, BT
    Chapman, W
    Neumann, CS
    Gearty, JC
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (06) : 727 - 733
  • [4] Chemoprevention and Barrett's Esophagus: Decisions, Decisions
    Falk, Gary W.
    Jankowski, Janusz
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (10) : 2443 - 2445
  • [5] Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications
    Kedika, Ramalinga R.
    Souza, Rhonda F.
    Spechler, Stuart Jon
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2009, 54 (11) : 2312 - 2317
  • [6] Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing
    Kuipers, Ernst J.
    [J]. GUT, 2010, 59 (02) : 148 - 149
  • [7] Nonsteroidal Anti-inflammatory Drug Use Reduces Risk of Adenocarcinomas of the Esophagus and Esophagogastric Junction in a Pooled Analysis
    Liao, Linda M.
    Vaughan, Thomas L.
    Corley, Douglas A.
    Cook, Michael B.
    Casson, Alan G.
    Kamangar, Farin
    Abnet, Christian C.
    Risch, Harvey A.
    Giffen, Carol
    Freedman, Neal D.
    Chow, Wong-Ho
    Sadeghi, Shahram
    Pandeya, Nirmala
    Whiteman, David C.
    Murray, Liam J.
    Bernstein, Leslie
    Gammon, Marilie D.
    Wu, Anna H.
    [J]. GASTROENTEROLOGY, 2012, 142 (03) : 442 - U85
  • [8] Medications (NSAIDs, Statins, Proton Pump Inhibitors) and the Risk of Esophageal Adenocarcinoma in Patients With Barrett's Esophagus
    Nguyen, Dang M.
    Richardson, Peter
    El-Serag, Hashem B.
    [J]. GASTROENTEROLOGY, 2010, 138 (07) : 2260 - 2266
  • [9] Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett's oesophagus: a systematic review and meta-analysis
    Singh, Siddharth
    Garg, Sushil Kumar
    Singh, Preet Paul
    Iyer, Prasad G.
    El-Serag, Hashem B.
    [J]. GUT, 2014, 63 (08) : 1229 - 1237
  • [10] Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
    Singh, Siddharth
    Singh, Abha Goyal
    Singh, Preet Paul
    Murad, Mohammad Hassan
    Iyer, Prasad G.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2013, 11 (06) : 620 - 629
12